Wednesday, October 06, 2021 10:09:22 AM
We Know, Biotech stock GLSI ran from $3 through $158 in a single day couple of months ago! I think SBFM is NEXT!!
Know What You Own:
Sunshine Biopharma Files a Patent Application Covering mRNA Molecules for Treatment of Neurodegenerative Diseases
MONTREAL, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has filed a patent application for a potential new treatment for neurodegenerative disorders. Sunshine Biopharma’s patent application contains experimental results showing that certain mRNA molecules provide protective effects against oxidative stress in differentiated neuronal cells, a process that mimics neuronal degeneration. This new patent application has a priority date of October 1, 2021.
Neurodegeneration refers to the progressive loss of neuronal function, which may ultimately result in cell death. Neurodegenerative diseases include amyotrophic lateral sclerosis (ALS), Parkinson's disease, multiple sclerosis, Alzheimer's disease, and Huntington's disease. Neurodegeneration can occur in the brain as well as in the peripheral nervous system. At present, there is no known way to reverse the progressive degeneration of neurons and as such these diseases are considered to be incurable.
Recent biochemical studies have revealed many underlying similarities among these diseases at the sub-cellular level. These similarities suggest that a given therapeutic approach for one neurodegenerative disease might ameliorate other diseases in the class.
Neurodegenerative diseases affect millions of people worldwide. Alzheimer’s disease and Parkinson’s disease are the most common neurodegenerative diseases. According to the CDC, as many as 5.8 million Americans were living with Alzheimer's disease in 2020. An estimated 1.2 million people in the United States could be living with Parkinson’s disease by 2030. There is currently no way to slow down the progression of these and other neurodegenerative diseases.
“We are heartened by this recent finding in our ongoing mRNA-as-therapeutic-agents research that certain mRNA molecules provide differentiated neuronal cells full protection against hydrogen peroxide induced oxidative stress, a system commonly used to study neurodegeneration in vitro,” said Dr. Steve Slilaty, CEO of Sunshine Biopharma. “We are excited about this discovery for patients suffering from neurodegenerative disorders. Our possible mRNA treatment could arrest progression of neurodegeneration, alleviate symptoms, relieve pain, and increase mobility,” he added.
https://ca.finance.yahoo.com/news/sunshine-biopharma-files-patent-application-120000636.html
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern, 2021-08-12 !! Just amazing !!
https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000512.html
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer, 2021-07-08!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-employs-mrna-vaccine-130000648.html
Sunshine Biopharma’s Adva-27a Destroys Cancer Cells Expressing P-glycoprotein, a Marker Present in Over 50% of All Cancer Types, 2021-05-25 - This is gonna be HUGE beyond imagination!
https://ca.finance.yahoo.com/news/sunshine-biopharma-adva-27a-destroys-120000080.html
Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application, 2021-05-04.
https://ca.finance.yahoo.com/news/sunshine-biopharma-upgrades-covid-19-120000354.html
Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment, 2021-04-19..Just amazing!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-favorable-mtd-120000152.html
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a, the Company's Flagship Anticancer Compound Until 2033-Just Beautiful!
https://finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-130000340.html
SBFM has a number of shares outstanding only 510.09 million including restricted shares of 60.01 Million. Biotech stock with huge potential and such a low OS in OTC, PPS @ $2..$5..$7..$10..$20..$25++??, anything is possible.
https://www.otcmarkets.com/stock/SBFM/security
Shorts are Screwed up here. Total Naked Shorted Position is 15.313 Million. Huge Short Squeeze is imminent. Shorts are gonna be scrambling, weeping and biting their nails.
https://marketwirenews.com/stock/sbfm/short/
Let's go SBFM to $5++ and NASDAQ !!
SHARE VALUATION:
As per MNP (one of the largest public accountancy firms in Canada), an estimated Fair Market Value of issued and outstanding shares of SBFM as at March 31, 2017 was in the range of $977.0 million to $1,133.0 million.
https://finance.yahoo.com/news/sunshine-biopharma-releases-results-independent-130000009.html
So, Estimated PPS of SBFM (in 2017) = $1,100 million/510.09 million = $2.16 (without recent developments)
Folks! act prudently and be financially solvent at this very very difficult time.
RECENT DEVELOPMENTS:
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-0-9-130000806.html
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned, 2021-06-09
https://ca.finance.yahoo.com/news/sunshine-biopharma-mice-study-covid-130000849.html
Sunshine Biopharma Eliminates $250,000 in Variable Rate Convertible Debt and Provides an Update on Status of OTCQB Uplisting
https://ca.finance.yahoo.com/news/sunshine-biopharma-eliminates-250-000-120000108.html
Sunshine Biopharma Reports $1.797 Million Cash in 2021 Q1 Filing
https://ca.finance.yahoo.com/news/sunshine-biopharma-reports-improved-cash-120000104.html
RB Capital Increases Investment in Sunshine Biopharma
https://ca.finance.yahoo.com/news/rb-capital-increases-investment-sunshine-120000335.html
Sunshine Biopharma Reaches $2,000,000+ Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-reaches-2-000-130000199.html
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033, 2021-03-11
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-notice-allowance-140000158.html
Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-recently-ordered-140000929.html
Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements
https://ca.finance.yahoo.com/news/sunshine-biopharma-launches-ecommerce-store-141400955.html
Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds, Feb. 4, 2021
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-exclusive-license-130000848.html
Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
https://ca.finance.yahoo.com/news/sunshine-biopharma-receives-fourth-tranche-133000911.html
Sunshine Biopharma’s Coronavirus Treatment Anticipated to Be Effective Against the New Variant Identified in the UK, Dec. 22, 2020
https://ca.finance.yahoo.com/news/sunshine-biopharma-coronavirus-treatment-anticipated-130000305.html
Sunshine Biopharma Orders a New Batch of Adva-27a for Testing on TOPII Amplified Cancers, Dec. 8, 2020
https://ca.finance.yahoo.com/news/sunshine-biopharma-orders-batch-adva-130000761.html
Sunshine Biopharma Paid Off Convertible Notes in Cash Preventing New Shares From Hitting the Market, December 3, 2020..Just Beautiful!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-pays-off-convertible-130000473.html
Sunshine Biopharma Signed an Agreement with a Montreal-based Company to Advance the Development of Adva-27a Anticancer Compound....This is a HUGE NEWS!!
https://ca.finance.yahoo.com/news/sunshine-biopharma-signs-agreement-montreal-130000919.html
https://wallstreetwindow.com/2020/10/shares-of-sunshine-biopharma-inc-otcmkts-sbfm-rise-today-on-covid-drug-news-tim-bellamy-10-19-2020/
Recent SBFM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
- Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM